PGP and neoplasm: Therefore, in our earlier study we utilized JS-K, a tumor specific NO-donor, activated by GSH/GSH transferase system in tumors [19], and found that JS-K was extremely effective in reversing P-gp-mediated resistance of ADR in a P-gp-overexpressing human tumor cell line.